# NasoShield in Healthy Adults to Study Safety and Immunogenicity

> **NCT04415749** · PHASE1 · COMPLETED · sponsor: **Altimmune, Inc.** · enrollment: 43 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** NasoShield
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04415749
- **Lead sponsor:** Altimmune, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-15
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-03-15
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04415749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04415749, "NasoShield in Healthy Adults to Study Safety and Immunogenicity". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04415749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*